Throughout the last three months, 7 analysts have evaluated Vir Biotechnology (NASDAQ:VIR), offering a diverse set of opinions from bullish to bearish. The table below provides a snapshot of their ...
Hosted on MSN1mon
Vir Biotechnology appoints new Chief Technical OfficerVir Biotechnology, listed on the Nasdaq Global Select Market under the ticker symbol (NASDAQ:VIR), operates within the biotechnology industry, focusing on the development of treatments for serious ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback